We, at BioStrand, are on a mission to make genomic analysis effective and available for every researcher.
Today, genomic data analysis is a complex series of operations. Often only specially trained professionals are able to perform these analyses. Costly subscriptions to compute and store these genomic data are needed. Despite all the efforts, current analysis is far from flawless and contains huge amounts of errors.
To make fundamental progress in precision medicine, agrochemical and food technology, these problems will have to be tackled first. We, at BioStrand, can solve these problems.
We are working hard to create a platform that brings together everyone involved in genetics, so that our technology can revolutionise the genetic research being done in R&D departments at pharmaceutical, biotechnology, diagnostic, agrochemical and food technology companies.
Contact us today to set up a meeting with one of our experts or request a demo.
Our Innovative Technology
BioStrand is the first company since the 1980s to come up with a completely new, out-of-the-box solution for genetic data analysis. Where next generation sequencing revolutionised sequence data generation in the last decade, BioStrand now revolutionises sequence data analysis.
BioStrand offers a revolutionary methodology for identifying similarities and variations in genetic data and detecting structural anchor points that will drive innovation.
The BioStrand methodology enables unprecedented accuracy and speed of operation in detecting similarities and variations in DNA, RNA and proteins. By detecting HYFTSTM, structural 3D information is automatically integrated into the analyses, revolutionising pattern and profile detection that are critical in understanding diseases and biological processes.
With our fundamentally new method we make sure that genomic data analysis finally can keep pace with genetic data generation.
We unlock the true potential present in omics data and close the gaps towards precision medicine. Just in time.
Sign up and test our MVP!
BioStrand was born from the recognition that genetics analysis needed significant improvements.
Founded by a family team with decades of experience in the medical and research fields, we spent seven years conducting private research about genetic analysis technology, the major barriers, and the potential opportunities. Inspired by cross-domain knowledge stemming from text analytics to evolutionary biology, we developed the formulation of hypotheses, designed algorithms to test them and further expanded our initial ideas. Step by step the project grew until we had a working prototype.
Feb 6, 2019 we founded the company and filed a patent
MVP for first platform finalised
May 15, 2020 we raised 2 M Euros in a seed round. K&E, the Holding behind Globachem invested
We welcomed 3 new data scientists/engineers. We received a 235 K Euros Innovation Grant from the Flemish Government
We began beta testing of MVP with companies across various industries such as biotech and agricultural research
Upcoming milestones: New features for advanced annotation/recommendation engine and variation analysis to be launched
Our culture and values
Outside-the-box thinking is our natural attitude. Innovative ideas arise from creative thinking and fast failure.
Do what you say and say what you do. Achieving great things is only possible when working together in a relationship based on mutual trust and respect.
We operate in a cross-domain environment. Great achievements are always the result of teamwork. The whole is greater than the sum of its parts.
We are not only colleagues, we are the BioStrand family. Working hard also means having fun and caring for each other.
"Healthy scepticism is the basis of all accurate observation."
- Arthur Conan Doyle